- ￥896
- ProSpec
- CYT-366
- 以色列
- 2026年01月31日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
北京鼎国昌盛
- 库存：
大量
- 英文名：
Recombinant Human Cytotoxic T-Lymphocyte Associated Antigen-4
- 规格：
10µg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验antigens (Ag) complexed to MHC class I molecules (6 ,7 ). Immunization with virus-infected antigen-presenting cells (APC) or Ag-expressing transfectants, and even APC osmotically loaded with antigens can elicit CD8+ cytotoxic T-cells (8 –10
Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma
Therapeutic strategies that block Cytotoxic T lymphocyte antigen-4 (CTLA-4) enhance antitumor immunity and prolong the lives of patients with metastatic melanoma. However, only a subset of patients benefit, and responses are often delayed
The Cytotoxic T Lymphocyte Assay for Evaluating Cell-Mediated Immune Function
Evaluation of cell-mediated immunity (CMI) is a significant component in any assessment designed to predict the full range of potential immunotoxic risk underlying health risks. Among measures of CMI, the cytotoxic T Lymphocyte (CTL) response
技术资料暂无技术资料 索取技术资料
